| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.82▼ | 1.81▼ | 1.81▼ | 1.77▲ |
| MA10 | 1.81▼ | 1.81▼ | 1.81▼ | 1.78▲ | 2.04▼ |
| MA20 | 1.82▼ | 1.82▼ | 1.82▼ | 1.76▲ | 2.52▼ |
| MA50 | 1.81▼ | 1.78▲ | 1.76▲ | 2.11▼ | 2.05▼ |
| MA100 | 1.75▲ | 1.75▲ | 1.78▲ | 2.65▼ | 1.36▲ |
| MA200 | 1.75▲ | 1.94▼ | 2.02▼ | 2.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.007▼ | -0.007▼ | 0.037▲ | -0.173▼ |
| RSI | 45.432▼ | 46.978▼ | 47.437▼ | 43.463▼ | 43.370▼ |
| STOCH | 30.240 | 40.044 | 40.044 | 55.010 | 12.915▼ |
| WILL %R | -91.667▼ | -91.667▼ | -91.667▼ | -69.333 | -87.395▼ |
| CCI | -78.014 | -103.453▼ | -102.960▼ | 39.307 | -76.464 |
|
Thursday, May 01, 2025 07:30 AM
Company initiates formal regulatory engagement on trial design for Alzheimer’s, dementia, and MCI indicationsHOUSTON, TX, May 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) ...
|
|
Thursday, May 01, 2025 07:30 AM
Company initiates formal regulatory engagement on trial design for Alzheimer’s, dementia, and MCI indicationsHOUSTON, TX, May 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.85 | 1.92 | 1.755 | 1.79 | 55,119 |
| 30/04/25 | 1.89 | 1.89 | 1.76 | 1.82 | 20,878 |
| 29/04/25 | 1.81 | 1.87 | 1.81 | 1.81 | 17,378 |
| 28/04/25 | 1.91 | 1.924 | 1.7601 | 1.82 | 47,089 |
| 25/04/25 | 1.81 | 1.87 | 1.77 | 1.83 | 34,506 |
| 24/04/25 | 1.79 | 1.88 | 1.71 | 1.85 | 43,302 |
| 23/04/25 | 1.82 | 1.8916 | 1.73 | 1.75 | 47,643 |
| 22/04/25 | 1.77 | 1.79 | 1.70 | 1.74 | 47,800 |
| 21/04/25 | 1.67 | 1.81 | 1.661 | 1.734 | 54,600 |
| 17/04/25 | 1.67 | 1.75 | 1.616 | 1.689 | 39,700 |
|
|
||||
|
|
||||
|
|